Functional analysis of sucrase-isomaltase mutations from chronic lymphocytic leukemia patients

Human Molecular Genetics

Volumn 22, Issue 11, 2013, Pages 2273-2282

  Rodríguez, David ^a   Ramsay, Andrew J ^a   Quesada, Víctor ^a   Garabaya, Cecilia ^a   Campo, Elías ^b   Freije, José M P ^a   López Otín, Carlos Ló ^a  

^a UNIVERSITY OF OVIEDO   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

RNA; SUCRASE ISOMALTASE; TRANSCRIPTOME;

ARTICLE; CANCER PATIENT; CATALYSIS; CELL SURFACE; CHRONIC LYMPHATIC LEUKEMIA; COHORT ANALYSIS; CONTROLLED STUDY; ENZYME METABOLISM; ENZYME SYNTHESIS; GENE EXPRESSION; GENE FREQUENCY; GENETIC ANALYSIS; HUMAN; HUMAN CELL; LOSS OF FUNCTION MUTATION; MAJOR CLINICAL STUDY; NUCLEAR REPROGRAMMING; PRIORITY JOURNAL; TRANSCRIPTOMICS;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE; CLUSTER ANALYSIS; GENE EXPRESSION PROFILING; HUMANS; INTRACELLULAR SPACE; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; METABOLIC NETWORKS AND PATHWAYS; MUTATION; PROTEIN TRANSPORT; SEQUENCE ALIGNMENT; SIGNAL TRANSDUCTION; SUCRASE-ISOMALTASE COMPLEX;

EID: 84877894013     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddt078     Document Type: Article

References (48)

1. Chiorazzi, N., Rai, K.R. and Ferrarini, M. (2005) Chronic lymphocytic leukemia. N. Engl. J. Med., 352, 804-815.
2. Rozman, C. and Montserrat, E. (1995) Chronic lymphocytic leukemia. N. Engl. J. Med., 333, 1052-1057.
3. Zenz, T., Mertens, D., Küppers, R., Döhner, H. and Stilgenbauer, S. (2010) From pathogenesis to treatment of chronic lymphocytic leukaemia. Nat. Rev. Cancer, 10, 37-50.
4. Puente, X.S. and López-Otidotlesśn, C. (2013) The evolutionary biography of chronic lymphocytic leukemia. Nat. Genet, 45. doi: 10.1038/ng.2556.
5. Damle, R.N., Wasil, T., Fais, F., Ghiotto, F., Valetto, A., Allen, S.L., Buchbinder, A., Budman, D., Dittmar, K., Kolitz, J. et al. (1999) Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood, 94, 1840-1847.
6. Hamblin, T.J., Davis, Z., Gardiner, A., Oscier, D.G. and Stevenson, F.K. (1999) Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood, 94, 1848-1854.
7. Puente, X.S., Pinyol, M., Quesada, V., Conde, L., Ordónogonekez, G.R., Villamor, N., Escaramis, G., Jares, P., Bea', S., González-Díaz, M. et al. (2011) Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature, 475, 101-105.
8. Fabbri, G., Rasi, S., Rossi, D., Trifonov, V., Khiabanian, H., Ma, J., Grunn, A., Fangazio, M., Capello, D., Monti, S. et al. (2011) Analysis ofthe chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation. J. Exp. Med., 208, 1389-1401.
9. Quesada, V., Conde, L., Villamor, N., Ordónogonekez, G.R., Jares, P., Bassaganyas, L.,Ramsay, A.J.,Bea', S., Pinyol,M.,Martidotlesśnez-Trillos,A. et al. (2011)Exome sequencing identifies recurrentmutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia. Nat. Genet., 44, 47-52.
10. Quesada, V., Ramsay, A.J. and Lopez-Otin, C. (2012) Chronic lymphocytic leukemia with SF3B1 mutation. N. Engl. J. Med., 366, 2530.
11. Rossi, D., Bruscaggin, A., Spina, V., Rasi, S., Khiabanian, H., Messina, M., Fangazio, M., Vaisitti, T., Monti, S., Chiaretti, S. et al. (2011) Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness. Blood, 118, 6904-6908.
12. Wang, L., Lawrence, M.S., Wan, Y., Stojanov, P., Sougnez, C., Stevenson, K., Werner, L., Sivachenko, A., DeLuca, D.S., Zhang, L. et al. (2011) SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. N. Engl. J. Med., 365, 2497-2506.
13. Ramsay, A.J., Quesada, V., Foronda, M., Conde, L., Martinez-Trillos, A., Villamor, N., Rodridotlesśguez, D., Kwarciak, A., Gallardo, M., López-Guillermo, A. et al. (2013) POT1 mutations cause telomere dysfunction in chronic lymphocytic leukemia. Nat. Genet., doi:10.1038/ ng.2584.
14. Ramsay, A.J., Martidotlesśnez-Trillos, A., Jares, P., Rodridotlesśguez, D., Kwarciack, A. and Quesada, V. (2012) Next generation sequencing reveals the secrets of the chronic lymphocytic laeukemia genome. Clin. Transl. Oncol., 15, 3-8.
15. Nagarajan, P., Onami, T.M., Rajagopalan, S., Kania, S., Donnell, R. and Venkatachalam, S. (2009) Role of chromodomain helicase DNA-binding protein 2 in DNA damage response signaling and tumorigenesis. Oncogene, 28, 1053-1062.
16. Prazeres, H., Torres, J., Rodrigues, F., Pinto, M., Pastoriza, M.C., Gomes, D., Cameselle-Teijeiro, J., Vidal, A., Martins, T.C., Sobrinho-Simoogonekes, M. et al. (2011) Chromosomal, epigenetic and microRNA-mediated inactivation of LRP1B, a modulator of the extracellular environment of thyroid cancer cells. Oncogene, 30, 1302-1317.
17. Hauser, H. and Semenza, G. (1983) Sucrase-isomaltase: a stalked intrinsic protein of the brush bordermembrane. CRC Crit. Rev. Biochem., 14, 319-345.
18. Naim, H.Y., Sterchi, E.E. and Lentze, M.J. (1988) Biosynthesis of the human sucrase-isomaltase complex. Differential O-glycosylation of the sucrase subunit correlates with its position within the enzyme complex. J. Biol. Chem., 263, 7242-7253.
19. Hauri, H.-P., Quaroni, A. and Isselbacher, K.J. (1979) Biogenesis of intestinal plasma membrane: Posttranslational route and cleavage of sucrase-isomaltase. Proc. Natl Acad. Sci. USA, 76, 5183-5186.
20. Pröpsting, M.J., Kanapin, H., Jacob, R. and Naim, H.Y. (2005) A phenylalanine-based folding determinant in intestinal sucrase-isomaltase that functions in the context of a quality control mechanism beyond the endoplasmic reticulum. J. Cell Sci., 118, 2775-2784.
21. Alfalah, M., Keiser, M., Leeb, T., Zimmer, K.-P. and Naim, H.Y. (2009) Compound heterozygous mutations affect protein folding and function in patients with congenital sucrase-isomaltase deficiency. Gastroenterology, 136, 883-892.
22. Wiltz, O., O'Hara, C.J., Steele, G.D. and Mercurio, A.M. (1990) Sucrase-isomaltase: a marker associated with the progression of adenomatous polyps to adenocarcinomas. Surgery, 108, 269-276.
23. Wiltz, O., O'Hara, C.J., Steele, G.D.J. and Mercurio, A.M. (1991) Expression of enzymatically active sucrase-isomaltase is a ubiquitous property of colon adenocarcinomas. Gastroenterology, 100, 1266-1278.
24. Hanahan, D. and Weinberg, R.A. (2011) Hallmarks of cancer: the next generation. Cell, 144, 646-674.
25. DeBerardinis, R.J. and Thompson, C.B. (2012) Cellular metabolism and disease: what do metabolic outliers teach us Cell, 148, 1132-1144.
26. Burnichon, N., Brie're, J.J., Libé, R., Vescovo, L., Rivie're, J., Tissier, F., Jouanno, E., Jeunemaitre, X., Bénit, P., Tzagoloff, A. et al. (2010) SDHA is a tumor suppressor gene causing paraganglioma. Hum. Mol. Genet., 19, 3011-3020.
27. Ni, Y., He, X., Chen, J., Moline, J., Mester, J., Orloff, M.S., Ringel, M.D. and Eng, C. (2012) Germline SDHx variants modify breast and thyroid cancer risks in Cowden and Cowden-like syndrome via FAD/ NAD-dependant destabilization of p53. Hum. Mol. Genet., 21, 656-663.
28. Alam, N.A., Rowan, A.J., Wortham, N.C., Pollard, P.J., Mitchell, M., Tyrer, J.P., Barclay, E., Calonje, E., Manek, S., Adams, S.J. et al. (2003) Genetic and functional analyses of FH mutations in multiple cutaneous and uterine leiomyomatosis, hereditary leiomyomatosis and renal cancer, and fumarate hydratase deficiency. Hum. Mol. Genet., 12, 1241-1252.
29. Tomlinson, I.P., Alam, N.A., Rowan, A.J., Barclay, E., Jaeger, E.E., Kelsell, D., Leigh, I., Gorman, P., Lamlum, H., Rahman, S. et al. (2002) Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat. Genet., 30, 406-410.
30. Dang, L., White, D.W., Gross, S., Bennett, B.D., Bittinger, M.A., Driggers, E.M., Fantin, V.R., Jang, H.G., Jin, S., Keenan, M.C. et al. (2009) Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature, 462, 739-744.
31. Hunziker, W., Spiess, M., Semenza, G. and Lodish, H.F. (1986) The sucrase-isomaltase complex: primary structure, membrane-orientation, and evolution of a stalked, intrinsic brush border protein. Cell, 46, 227-234.
32. Keiser, M., Alfalah, M., Pröpsting, M.J., Castelletti, D. and Naim, H.Y. (2006) Altered folding, turnover, and polarized sorting act in concert to define a novel pathomechanism of congenital sucrase-isomaltase deficiency. J. Biol. Chem., 281, 14393-14399.
33. Manders, E.M.M., Verbeek, F.J. and Aten, F.J. (1993) Measurement of localization of objects in dual-color confocal images. J. Microsc., 169, 375-382.
34. Alfalah, M., Jacob, R., Preuss, U., Zimmer, K.-P., Naim, H. and Naim, H.Y. (1999) O-linked glycans mediate apical sorting of human intestinal sucrase-isomaltase through association with lipid rafts. Curr. Biol., 9, 593-596.
35. Wetzel, G., Heine, M., Rohwedder, A. and Naim, H.Y. (2009) Impact of glycosylation and detergent-resistant membranes on the function of intestinal sucrase-isomaltase. Biol. Chem., 390, 545-549.
36. Lee, S.H., Yu, S.-Y., Nakayama, J., Khoo, K.-H., Stone, E.L., Fukuda, M.N., Marth, J.D. and Fukuda, M. (2010) Core2 O-Glycan structure is essential for the cell surface expression of sucrase isomaltase and dipeptidyl peptidase-IV during intestinal cell differentiation. J. Biol. Chem., 285, 37683-37692.
37. Hudson, T.J., Anderson, W., Artez, A., Barker, A.D., Bell, C., Bernabé, R.R., Bhan, M.K., Calvo, F., Eerola, I., Gerhard, D.S. et al. (2010) International network of cancer genome projects. Nature, 464, 993-998.
38. Nichols, B.L., Avery, S., Sen, P., Swallow, D.M., Hahn, D. and Sterchi, E. (2003) The maltase-glucoamylase gene: common ancestry to sucrase-isomaltase with complementary starch digestion activities. Proc. Natl Acad. Sci. USA, 100, 1432-1437.
39. Naim, H.Y., Roth, J., Sterchi, E.E., Lentze, M., Milla, P., Schmitz, J. and Hauri, H.-P. (1988) Sucrase-isomaltase deficiency in humans. Different mutations disrupt intracellular transport, processing, and function of an intestinal brush border enzyme. J. Clin. Invest., 82, 667-679.
40. Sjostrom, H., Norén, O. and Danielsen, E.M. (1985) Enzymatic activity of 'high-mannose' glycosylated forms of intestinal microvillar hydrolases. J. Pediatr. Gastroenterol. Nutr., 4, 980-983.
41. Hoffmann, W. and Hauser, F. (1993) The P-domain or trefoil motif: a role in renewal and pathology of mucous epithelia Trends Biochem. Sci., 18, 239-243.
42. Spodsberg, N., Jacob, R., Alfalah, M., Zimmer, K.-P. and Naim, H.Y. (2001) Molecular basis of aberrant apical protein transport in an intestinal enzyme disorder. J. Biol. Chem., 276, 23506-23510.
43. Jacob, R., Pürschel, B. and Naim, H.Y. (2002) Sucrase is an intramolecular chaperone located at the C-terminal end of the sucrase-isomaltase enzyme complex. J. Biol. Chem., 277, 32141-32148.
44. Ritz, V., Alfalah, M., Zimmer, K.-P., Schmitz, J., Jacob, R. and Naim, H.Y. (2003) Congenital sucrase-isomaltase deficiency because of an accumulation of the mutant enzyme in the endoplasmic reticulum. Gastroenterology, 125, 1678-1685.
45. Hsu, P.P. and Sabatini, D.M. (2008) Cancer cell metabolism: Warburg and beyond. Cell, 134, 703-707.
46. Chantret, I., Rodolosse, A., Barbat, A., Dussaulx, E., Brot-Laroche, E., Zweibaum, A. and Rousset, M. (1994) Differential expression of sucrase-isomaltase in clones isolated from early and late passages of the cell line Caco-2: evidence for glucose-dependent negative regulation. J. Cell Sci., 107, 213-225.
47. Keller, P., Semenza, G. and Shaltiel, S. (1995) Phosphorylation of the N-terminal intracellular tail of sucrase-isomaltase by cAMP-dependent protein kinase. Eur. J. Biochem., 233, 963-968.
48. Servant, N., Gravier, E., Gestraud, P., Laurent, C., Paccard, C., Biton, A., Brito, I., Mandel, J., Asselain, B., Barillot, E. et al. (2010) EMA-A R package for Easy Microarray data analysis. BMC Res. Notes, 3, 277.